Drug-safety-monitoring

Unlocking value - Dr Andrew Rut in PharmaTimes

News
06/12/19

In his latest PharmaTimes article, Dr Andrew Rut looks ahead to 2020 and outlines the trends we might well see emerge in the New Year. This includes the coming of age of precision medicines, where better insights into disease and earlier decision-making for precise targeting of interventions will be supported by high value and high volume adverse event data as part of programmes that enable patients to feedback adherence and safety data in real-time.

Read the full article here.


Request More Information

To find out more or request a demo fill in the details below:


For more information contact chris.beverley@mymedsandme.com

Keep informed

For expert insight and updates from the MyMeds&Me team.

We respect your privacy and we will only use your email address for newsletters and company updates